Definitive Contract 75F40121C00130

Award Date 9/23/21
Potential Completion Date 11/29/24
Potential Value $480K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Pocatello, ID 83209, USA
Solicitation Procedures
Basic Research
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $3,539,788.80 firm-fixed price definitive contract awarded by the U.S. Department of Health and Human Services Food and Drug Administration (FDA) to International Consulting Associates, Inc. (ICA), an SBA-certified 8(a) minority-owned small disadvantaged business. The contract is for the scale-up of an existing Medical Device Evaluation (MDE) Artificial Intelligence (AI) pilot to an operational tool. ICA has an extensive track record supporting federal health agencies like HHS and...
The U.S. Food and Drug Administration (FDA) has awarded a $4,077,696.00 Firm Fixed Price, Definitive Contract to International Consulting Associates, Inc. (ICA) to develop AI-enabled user workflows and dashboards for the Center for Devices and Radiological Health (CDRH). This 8(a) sole source contract, running through September 2024, is part of the FDA's broader "ADVANCING REGULATORY SCIENCE FOR CLINICAL EVIDENCE GENERATION, ASSESSMENT, AND ANALYTICS" initiative. ICA, an...
This $436,800 firm fixed price contract was awarded by the Department of Health and Human Services Food and Drug Administration to Research Triangle Institute - doing business as R T I International, with place of performance in Research Triangle Park, North Carolina. The contract is for HDDISWP#115 BENEFIT-RISK PREFERENCES FOR THE USE OF ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING IN IMAGING DIAGNOSTICS, with a period of performance from September 2020 through December 2022. The award was made...
This is a $4,174,814.40 definitive, firm-fixed-price contract awarded by the Food and Drug Administration (FDA) to International Consulting Associates, Inc. (ICA), an SBA-certified 8(a), minority-owned, small disadvantaged business. The contract is for the development of an artificial intelligence (AI) tool to predict alerts related to medical devices under the Center for Devices and Radiological Health (CDRH). This sole-source, 8(a) set-aside contract will run through September 24, 2024. ICA is...
This federal contract award, valued at $811,126.00, was issued by the U.S. Food and Drug Administration (FDA) to Digital Medicine Society Inc., a non-profit organization based in Boston, Massachusetts. The contract was awarded under a Broad Agency Announcement (BAA) solicitation for research and development to support the FDA's regulatory science and innovation mission. The contract is a Definitive Contract with a Firm Fixed Price pricing type, and has an ultimate completion date of December 31,...
This is a Firm Fixed Price Blanket Purchase Agreement (BPA) call contract awarded by the Food and Drug Administration (FDA) to International Consulting Associates, Inc. (ICA), an SBA-certified 8(a), minority-owned, small disadvantaged business. The $28,209,345.33 contract supports the FDA's "ADVANCING REGULATORY SCIENCE FOR CLINICAL EVIDENCE GENERATION, ASSESSMENT, AND ANALYTICS" initiative, providing a range of data analytics, AI/ML, healthcare IT, and management consulting services...
This federal contract award is for DATA STANDARDS TESTING AND IMPLEMENTATION services, with a ceiling value of $2,737,337.22. The contract was awarded to the prime contractor, International Business Machines Corporation (IBM), by the Food and Drug Administration (FDA), a civilian agency. The contract does not have a set-aside designation. The contract is a BPA (Blanket Purchase Agreement) call under the Regulatory Review Support Services master BPA. This indicates that the services being...
This is a $647,382.17 firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to International Consulting Associates, Inc. (ICA), an SBA-certified 8(a) minority-owned small disadvantaged business. The contract is for the identification of real-world evidence (RWE) used in premarket regulatory submissions, supporting the FDA's "ADVANCING REGULATORY SCIENCE FOR CLINICAL EVIDENCE GENERATION, ASSESSMENT, AND ANALYTICS" initiative. ICA has an extensive track record...
This federal contract award for $3,885,609.18 was issued by the Food and Drug Administration (FDA), a civilian agency under the Department of Health and Human Services (HHS), to International Consulting Associates, Inc. (ICA), an SBA-certified 8(a), minority-owned, small disadvantaged business. The contract is for literature analysis services to support the Center for Devices and Radiological Health (CDRH) within the FDA. This is a definitive, firm fixed-price contract with a completion date...
The Food and Drug Administration (FDA) awarded a $3,821,128.80 firm-fixed-price contract to International Consulting Associates, Inc. (ICA), an SBA-certified 8(a), minority-owned, small disadvantaged business. This contract is part of the FDA's Center for Devices and Radiological Health's (CDRH) Medical Data Enterprise Initiative, which aims to streamline the use of real-world data and integrate it with CDRH data. ICA will provide advanced data analytics, artificial intelligence, healthcare...

This federal contract award, valued at $480,183.00, was made by the Food and Drug Administration (FDA) to Idaho State University to conduct research and development to understand patient information needs and the factors that influence patients' perceived value and trust of healthcare artificial intelligence (AI) applications. The goal is to develop guidance for the FDA and device manufacturers to ensure information is appropriate, transparent, and supports informed decision-making.

The contract was awarded through the FDA's Broad Agency Announcement (BAA) for Advanced Regulatory Science, which solicits research and development proposals across various areas of regulatory science to modernize the agency's functions. As an indefinite delivery/indefinite quantity contract vehicle, the BAA allows the FDA to acquire research and development support on an as-needed basis. There was no set-aside designation for this award.

Generated 6/20/24, 9:33 AM